| European consensus conference on faecal microbiota transplantation in clinical practice G Cammarota, G Ianiro, H Tilg, M Rajilić-Stojanović, P Kump, R Satokari, ... Gut 66 (4), 569-580, 2017 | 1237 | 2017 |
| Cancer chemoprevention by dietary polyphenols: promising role for epigenetics A Link, F Balaguer, A Goel Biochemical pharmacology 80 (12), 1771-1792, 2010 | 586 | 2010 |
| Fecal MicroRNAs as novel biomarkers for colon cancer screening A Link, F Balaguer, Y Shen, T Nagasaka, JJ Lozano, CR Boland, A Goel Cancer epidemiology, biomarkers & prevention 19 (7), 1766-1774, 2010 | 470 | 2010 |
| Epigenetic silencing of miR-137 is an early event in colorectal carcinogenesis F Balaguer, A Link, JJ Lozano, M Cuatrecasas, T Nagasaka, CR Boland, ... Cancer research 70 (16), 6609-6618, 2010 | 368 | 2010 |
| Helicobacter pylori: perspectives and time trends P Malfertheiner, A Link, M Selgrad Nature reviews Gastroenterology & hepatology 11 (10), 628-638, 2014 | 226 | 2014 |
| Curcumin modulates DNA methylation in colorectal cancer cells A Link, F Balaguer, Y Shen, JJ Lozano, HCE Leung, CR Boland, A Goel PloS one 8 (2), e57709, 2013 | 204 | 2013 |
| Boswellic acid exerts antitumor effects in colorectal cancer cells by modulating expression of the let-7 and miR-200 microRNA family M Takahashi, B Sung, Y Shen, K Hur, A Link, CR Boland, BB Aggarwal, ... Carcinogenesis 33 (12), 2441-2449, 2012 | 157 | 2012 |
| Gastric cancer–clinical and epidemiological aspects M Venerito, A Link, T Rokkas, P Malfertheiner Helicobacter 21, 39-44, 2016 | 154 | 2016 |
| MicroRNAs as non-invasive diagnostic biomarkers for gastric cancer: Current insights and future perspectives A Link, J Kupcinskas World Journal of Gastroenterology 24 (30), 3313, 2018 | 147 | 2018 |
| Circulating and fecal microRNAs as biomarkers for inflammatory bowel diseases K Schönauen, N Le, U von Arnim, C Schulz, P Malfertheiner, A Link Inflammatory bowel diseases 24 (7), 1547-1557, 2018 | 138 | 2018 |
| Colorectal cancers with microsatellite instability display unique miRNA profiles F Balaguer, L Moreira, JJ Lozano, A Link, G Ramirez, Y Shen, ... Clinical Cancer Research 17 (19), 6239-6249, 2011 | 124 | 2011 |
| A standardised model for stool banking for faecal microbiota transplantation: a consensus report from a multidisciplinary UEG working group JJ Keller, RE Ooijevaar, CL Hvas, EM Terveer, SC Lieberknecht, ... United European gastroenterology journal 9 (2), 229-247, 2021 | 122 | 2021 |
| Altered microbiota diversity and bile acid signaling in cirrhotic and noncirrhotic NASH-HCC S Sydor, J Best, I Messerschmidt, P Manka, R Vilchez-Vargas, ... Clinical and translational gastroenterology 11 (3), e00131, 2020 | 114 | 2020 |
| Macro-role of microRNA in gastric cancer A Link, J Kupcinskas, T Wex, P Malfertheiner Digestive diseases 30 (3), 255-267, 2012 | 112 | 2012 |
| Genetic Variation in HSD17B13 Reduces the Risk of Developing Cirrhosis and Hepatocellular Carcinoma in Alcohol Misusers F Stickel, P Lutz, S Buch, HD Nischalke, I Silva, V Rausch, J Fischer, ... Hepatology 72 (1), 88-102, 2020 | 108 | 2020 |
| Feasibility of fecal microRNAs as novel biomarkers for pancreatic cancer A Link, V Becker, A Goel, T Wex, P Malfertheiner Public Library of Science 7 (8), e42933, 2012 | 101 | 2012 |
| Current biomarkers for hepatocellular carcinoma: Surveillance, diagnosis and prediction of prognosis K Schütte, C Schulz, A Link, P Malfertheiner World journal of hepatology 7 (2), 139, 2015 | 99 | 2015 |
| The use of faecal microbiota transplantation (FMT) in Europe: a Europe-wide survey SMD Baunwall, EM Terveer, JF Dahlerup, C Erikstrup, P Arkkila, ... The Lancet Regional Health–Europe 9, 2021 | 95 | 2021 |
| Fusobacterium nucleatum is associated with worse prognosis in Lauren’s diffuse type gastric cancer patients ET Boehm, C Thon, J Kupcinskas, R Steponaitiene, J Skieceviciene, ... Scientific reports 10 (1), 16240, 2020 | 92 | 2020 |
| Helicobacter pylori infection is associated with a reduced risk of developing eosinophilic oesophagitis U Von Arnim, T Wex, A Link, M Messerschmidt, M Venerito, S Miehlke, ... Alimentary pharmacology & therapeutics 43 (7), 825-830, 2016 | 90 | 2016 |
Juozas KupcinskasMD, PhD, Department of Gastroenterology, Lithuanian University of Health SciencesПодтвержден адрес электронной почты в домене lsmu.lt
